荣昌生物：拟使用额度不超过25亿元的自有资金购买理财产品

Group 1 - The company Rongchang Biopharmaceutical announced the approval of an investment plan using its own funds, allowing for the purchase of financial products up to 2.5 billion RMB [1] - The financial products to be purchased must have high safety and good liquidity, and the purchasing institutions are not limited to banks and securities companies [1] - The approved investment amount is valid for one year from the date of the board's approval [1]